Related Experiment Video
Updated: Jun 26, 2026

06:13
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
Mucosal changes in chronic hypertrophic rhinitis after surgical turbinate reduction
George Gindros1, Ilias Kantas, Dimitrios G Balatsouras
1ENT Department, G.Genimmatas General Hospital, Thessaloníki, Greece.
Summary
Surgical turbinate reduction for chronic rhinitis shows limited epithelial healing. Ultrasound techniques offer some regeneration of nasal mucosa, but significant improvement is rare post-surgery.
Area of Science:
- Rhinology
- Otolaryngology
- Surgical Pathology
Background:
- Chronic hypertrophic rhinitis frequently causes nasal obstruction.
- Conservative treatments are often ineffective for this condition.
- Surgical turbinate reduction is a common treatment, but its histological effects are understudied.
Purpose of the Study:
- To compare the postoperative histological effects of submucosal monopolar diathermy, radiofrequency coblation, and ultrasound on nasal mucosa.
- To evaluate the regenerative capacity of the nasal epithelium after different turbinate reduction techniques.
Main Methods:
- Sixty patients with chronic hypertrophic rhinitis underwent turbinate reduction using ultrasound, monopolar diathermy, or radiofrequency coblation.
- Nasal mucosal specimens were collected preoperatively and at 1, 3, and 6 months post-surgery.
- Electron microscopy was used to examine epithelial changes, intercellular edema, mucus production, and collagen deposition.
Main Results:
- Preoperative mucosa showed epithelial degeneration, cilia loss, and inflammation.
- Postoperative specimens revealed reduced edema, less mucus, increased collagen, and flattened epithelium.
- Ultrasound treatment showed some areas of normally organized columnar ciliated epithelium.
Conclusions:
- Turbinate tissue volume reduction offers minimal improvement in epithelial changes associated with chronic hypertrophic rhinitis.
- Ultrasound techniques demonstrated limited epithelial regeneration in some cases, potentially restoring nasal physiology.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Pharyngitis
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
